Deltex Medical Group plc (DEMG.L)
GBp 0.08
(6.67%)
GBp 0.08
(6.67%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -1 Million GBP | 13.48% |
| 2022 | -890 Thousand GBP | 12.05% |
| 2021 | -748 Thousand GBP | -16.61% |
| 2020 | -531 Thousand GBP | -345.08% |
| 2019 | 196 Thousand GBP | 148.41% |
| 2018 | -731 Thousand GBP | 54.81% |
| 2017 | -1.47 Million GBP | 19.84% |
| 2016 | -1.94 Million GBP | 32.15% |
| 2015 | -3.08 Million GBP | -12.51% |
| 2014 | -2.73 Million GBP | -45.35% |
| 2013 | -1.79 Million GBP | -5.67% |
| 2012 | -1.77 Million GBP | -46.26% |
| 2011 | -1.23 Million GBP | -3.93% |
| 2010 | -1.19 Million GBP | 14.28% |
| 2009 | -1.92 Million GBP | 40.74% |
| 2008 | -2.47 Million GBP | -7.16% |
| 2007 | -2.15 Million GBP | -13.63% |
| 2006 | -1.95 Million GBP | -11.03% |
| 2005 | -1.69 Million GBP | 37.04% |
| 2004 | -2.69 Million GBP | -20.95% |
| 2003 | -2.23 Million GBP | 20.04% |
| 2002 | -2.79 Million GBP | 6.67% |
| 2001 | -3 Million GBP | -7.14% |
| 2000 | -3.5 Million GBP | -8.23% |
| 1999 | -2.58 Million GBP | -32.33% |
| 1998 | -2.55 Million GBP | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | -403 Thousand GBP | 0.0% |
| 2023 Q4 | -246 Thousand GBP | 0.0% |
| 2023 Q2 | -488 Thousand GBP | 0.0% |
| 2023 FY | - GBP | 13.48% |
| 2022 FY | - GBP | 12.05% |
| 2022 Q2 | -545 Thousand GBP | 0.0% |
| 2022 Q4 | -345 Thousand GBP | 0.0% |
| 2021 FY | - GBP | -16.61% |
| 2021 Q2 | -608 Thousand GBP | 0.0% |
| 2021 Q4 | -452 Thousand GBP | 0.0% |
| 2020 FY | - GBP | -345.08% |
| 2020 Q2 | -372 Thousand GBP | 0.0% |
| 2020 Q4 | -515 Thousand GBP | 0.0% |
| 2019 Q4 | 373 Thousand GBP | 0.0% |
| 2019 FY | - GBP | 148.41% |
| 2019 Q2 | -50 Thousand GBP | 0.0% |
| 2018 FY | - GBP | 54.81% |
| 2018 Q4 | 121 Thousand GBP | 0.0% |
| 2018 Q2 | -877 Thousand GBP | 0.0% |
| 2017 Q4 | -700 Thousand GBP | 0.0% |
| 2017 FY | - GBP | 19.84% |
| 2017 Q2 | -973 Thousand GBP | 0.0% |
| 2016 FY | - GBP | 32.15% |
| 2016 Q2 | -1.61 Million GBP | 0.0% |
| 2016 Q4 | -472 Thousand GBP | 0.0% |
| 2015 Q4 | -1.22 Million GBP | 0.0% |
| 2015 Q2 | -1.85 Million GBP | 0.0% |
| 2015 FY | - GBP | -12.51% |
| 2014 Q2 | -1.39 Million GBP | 0.0% |
| 2014 Q4 | -1.34 Million GBP | 0.0% |
| 2014 FY | - GBP | -45.35% |
| 2013 Q1 | -448.75 Thousand GBP | 0.0% |
| 2013 Q2 | -1.29 Million GBP | -188.13% |
| 2013 Q4 | -588 Thousand GBP | 0.0% |
| 2013 FY | - GBP | -5.67% |
| 2012 Q2 | -451 Thousand GBP | 0.0% |
| 2012 Q3 | -451 Thousand GBP | 0.0% |
| 2012 Q1 | -451 Thousand GBP | 0.0% |
| 2012 FY | - GBP | -46.26% |
| 2012 Q4 | -448.75 Thousand GBP | 0.5% |
| 2011 Q3 | -308 Thousand GBP | 0.0% |
| 2011 Q4 | -451 Thousand GBP | -46.43% |
| 2011 Q2 | -308 Thousand GBP | 0.0% |
| 2011 Q1 | -308 Thousand GBP | 0.0% |
| 2011 FY | - GBP | -3.93% |
| 2010 Q2 | -306 Thousand GBP | 0.0% |
| 2010 FY | - GBP | 14.28% |
| 2010 Q1 | -306 Thousand GBP | 0.0% |
| 2010 Q4 | -308 Thousand GBP | -0.65% |
| 2010 Q3 | -306 Thousand GBP | 0.0% |
| 2009 Q4 | -306 Thousand GBP | 36.48% |
| 2009 FY | - GBP | 40.74% |
| 2009 Q3 | -481.75 Thousand GBP | 0.0% |
| 2009 Q2 | -481.75 Thousand GBP | 0.0% |
| 2009 Q1 | -481.75 Thousand GBP | 0.0% |
| 2008 Q3 | -619 Thousand GBP | 0.0% |
| 2008 Q2 | -619 Thousand GBP | 0.0% |
| 2008 FY | - GBP | -7.16% |
| 2008 Q1 | -619 Thousand GBP | 0.0% |
| 2008 Q4 | -481.75 Thousand GBP | 22.17% |
| 2007 Q2 | -537.5 Thousand GBP | 0.0% |
| 2007 Q4 | -619 Thousand GBP | -15.16% |
| 2007 Q3 | -537.5 Thousand GBP | 0.0% |
| 2007 FY | - GBP | -13.63% |
| 2007 Q1 | -537.5 Thousand GBP | 0.0% |
| 2006 FY | - GBP | -11.03% |
| 2006 Q4 | -537.5 Thousand GBP | -9.97% |
| 2006 Q3 | -488.75 Thousand GBP | 0.0% |
| 2006 Q2 | -488.75 Thousand GBP | 0.0% |
| 2006 Q1 | -488.75 Thousand GBP | 0.0% |
| 2005 FY | - GBP | 37.04% |
| 2005 Q4 | -488.75 Thousand GBP | -15.07% |
| 2005 Q1 | -424.75 Thousand GBP | 0.0% |
| 2005 Q2 | -424.75 Thousand GBP | 0.0% |
| 2005 Q3 | -424.75 Thousand GBP | 0.0% |
| 2004 FY | - GBP | -20.95% |
| 2004 Q2 | -673.25 Thousand GBP | 0.0% |
| 2004 Q4 | -424.75 Thousand GBP | 36.91% |
| 2004 Q1 | -673.25 Thousand GBP | 0.0% |
| 2004 Q3 | -673.25 Thousand GBP | 0.0% |
| 2003 FY | - GBP | 20.04% |
| 2003 Q2 | -552 Thousand GBP | 0.0% |
| 2003 Q1 | -552 Thousand GBP | 0.0% |
| 2003 Q4 | -673.25 Thousand GBP | -21.97% |
| 2003 Q3 | -552 Thousand GBP | 0.0% |
| 2002 Q2 | -699.25 Thousand GBP | 0.0% |
| 2002 FY | - GBP | 6.67% |
| 2002 Q4 | -552 Thousand GBP | 21.06% |
| 2002 Q3 | -699.25 Thousand GBP | 0.0% |
| 2002 Q1 | -699.25 Thousand GBP | 0.0% |
| 2001 FY | - GBP | -7.14% |
| 2001 Q4 | -699.25 Thousand GBP | 3.55% |
| 2001 Q3 | -725 Thousand GBP | 0.0% |
| 2001 Q2 | -725 Thousand GBP | 0.0% |
| 2001 Q1 | -725 Thousand GBP | 0.0% |
| 2000 Q1 | -875 Thousand GBP | 0.0% |
| 2000 FY | - GBP | -8.23% |
| 2000 Q4 | -725 Thousand GBP | 17.14% |
| 2000 Q3 | -875 Thousand GBP | 0.0% |
| 2000 Q2 | -875 Thousand GBP | 0.0% |
| 1999 Q2 | -646.75 Thousand GBP | 0.0% |
| 1999 Q1 | -646.75 Thousand GBP | 0.0% |
| 1999 FY | - GBP | -32.33% |
| 1999 Q4 | -875 Thousand GBP | -35.29% |
| 1999 Q3 | -646.75 Thousand GBP | 0.0% |
| 1998 Q2 | -639.5 Thousand GBP | 0.0% |
| 1998 Q1 | -639.5 Thousand GBP | 0.0% |
| 1998 Q4 | -646.75 Thousand GBP | -1.13% |
| 1998 FY | - GBP | 0.0% |
| 1998 Q3 | -639.5 Thousand GBP | 0.0% |
| 1997 Q4 | -639.5 Thousand GBP | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|